CN105431202B - 骨移植物成骨潜能的增强 - Google Patents
骨移植物成骨潜能的增强 Download PDFInfo
- Publication number
- CN105431202B CN105431202B CN201480040557.6A CN201480040557A CN105431202B CN 105431202 B CN105431202 B CN 105431202B CN 201480040557 A CN201480040557 A CN 201480040557A CN 105431202 B CN105431202 B CN 105431202B
- Authority
- CN
- China
- Prior art keywords
- cells
- bone graft
- graft material
- wnt
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010166831.1A CN111643733B (zh) | 2013-07-16 | 2014-07-16 | 骨移植物成骨潜能的增强 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361957946P | 2013-07-16 | 2013-07-16 | |
| US61/957,946 | 2013-07-16 | ||
| PCT/US2014/046852 WO2015009829A2 (en) | 2013-07-16 | 2014-07-16 | Enhancement of osteogenic potential of bone grafts |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010166831.1A Division CN111643733B (zh) | 2013-07-16 | 2014-07-16 | 骨移植物成骨潜能的增强 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105431202A CN105431202A (zh) | 2016-03-23 |
| CN105431202B true CN105431202B (zh) | 2020-03-24 |
Family
ID=52346837
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480040557.6A Expired - Fee Related CN105431202B (zh) | 2013-07-16 | 2014-07-16 | 骨移植物成骨潜能的增强 |
| CN202010166831.1A Expired - Fee Related CN111643733B (zh) | 2013-07-16 | 2014-07-16 | 骨移植物成骨潜能的增强 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010166831.1A Expired - Fee Related CN111643733B (zh) | 2013-07-16 | 2014-07-16 | 骨移植物成骨潜能的增强 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9301980B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3021943B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6557659B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102307174B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105431202B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2014290042B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2916898A1 (cg-RX-API-DMAC7.html) |
| GB (2) | GB2578557B (cg-RX-API-DMAC7.html) |
| IL (1) | IL243288B (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016000464A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015009829A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201600095B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017023542A1 (en) | 2015-07-31 | 2017-02-09 | DePuy Synthes Products, Inc. | Method of preparing an osteogenic bone graft |
| US11491262B2 (en) * | 2018-04-19 | 2022-11-08 | Paulo Jose PASQUALI | Method of bone regeneration |
| EP3787645A4 (en) * | 2018-05-02 | 2022-06-01 | Ortheus, Inc. | SYSTEMS AND METHODS FOR LOCAL MODULATION OF WNT SIGNALING |
| CN111700881B (zh) * | 2020-07-02 | 2021-05-18 | 四川大学 | Wnt蛋白\ZIF-8纳米复合体、其制备方法及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1846793A (zh) * | 2005-04-14 | 2006-10-18 | 南方医院 | 一种组织工程骨及其构建与应用 |
| US20100247494A1 (en) * | 2009-03-23 | 2010-09-30 | The Texas A&M University System | Compositions of Mesenchymal Stem Cells to Regenerate Bone |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5550289A (en) | 1985-01-07 | 1996-08-27 | Syntex (U.S.A.) Inc. | N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5705655A (en) | 1992-12-17 | 1998-01-06 | Megabios Corporation | Amphiphilic nitrogen containing imidazolinium derivative compounds and uses |
| KR960705798A (ko) | 1993-11-24 | 1996-11-08 | 벤자민 에프 맥그로우 | 피페라진의 양쪽친화성 유도체(amphiphilic derivatives of piperazine) |
| KR960705771A (ko) | 1993-11-24 | 1996-11-08 | 벤자민 에프 맥그로우 | 구아니딘의 양쪽친화성 유도체(amphiphilic derivatives of guanidine) |
| CA2194221C (en) | 1994-06-22 | 2001-01-02 | Megabios Corporation | Cationic amphiphiles |
| DE19521412A1 (de) | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
| JP2004507236A (ja) * | 2000-08-18 | 2004-03-11 | プロスケリア | 骨粗鬆症の診断および治療に有用な調節遺伝子および系 |
| US6723131B2 (en) * | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
| EP1660663A4 (en) * | 2003-08-12 | 2007-07-11 | Brigham & Womens Hospital | METHOD AND COMPOSITIONS FOR TISSUE REPAIR |
| US8343922B2 (en) * | 2004-05-19 | 2013-01-01 | Enzo Biochem, Inc. | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| WO2008109119A2 (en) * | 2007-03-05 | 2008-09-12 | The Board Of Trustees Of The Leland Stanford Junior University | Wnt compositions and methods of use thereof |
| JP5458238B2 (ja) * | 2007-11-30 | 2014-04-02 | 一郎 小野 | 臓器再生用デバイス |
| US9526737B2 (en) | 2007-12-03 | 2016-12-27 | The Regents Of The University Of California | Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling |
| SI2331109T1 (sl) * | 2008-08-22 | 2013-10-30 | Anthrogenesis Corporation | Postopki in sestavki za zdravljenje okvar kosti s populacijami placentarnih celic |
| WO2012034070A1 (en) * | 2010-09-09 | 2012-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Use of liposomal wnt compositions to enhance osseointegration |
| WO2012135176A2 (en) * | 2011-03-28 | 2012-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | The use of wnt agents to prevent hypoxic injury |
-
2014
- 2014-07-16 EP EP14827030.9A patent/EP3021943B1/en active Active
- 2014-07-16 GB GB2001056.7A patent/GB2578557B/en not_active Expired - Fee Related
- 2014-07-16 CN CN201480040557.6A patent/CN105431202B/zh not_active Expired - Fee Related
- 2014-07-16 JP JP2016527073A patent/JP6557659B2/ja not_active Expired - Fee Related
- 2014-07-16 KR KR1020167002073A patent/KR102307174B1/ko not_active Expired - Fee Related
- 2014-07-16 WO PCT/US2014/046852 patent/WO2015009829A2/en not_active Ceased
- 2014-07-16 CN CN202010166831.1A patent/CN111643733B/zh not_active Expired - Fee Related
- 2014-07-16 US US14/333,220 patent/US9301980B2/en active Active
- 2014-07-16 AU AU2014290042A patent/AU2014290042B2/en not_active Ceased
- 2014-07-16 GB GB1600149.7A patent/GB2530224B/en not_active Expired - Fee Related
- 2014-07-16 MX MX2016000464A patent/MX2016000464A/es unknown
- 2014-07-16 CA CA2916898A patent/CA2916898A1/en active Pending
-
2015
- 2015-12-27 IL IL243288A patent/IL243288B/en active IP Right Grant
-
2016
- 2016-01-06 ZA ZA2016/00095A patent/ZA201600095B/en unknown
- 2016-03-07 US US15/063,317 patent/US9925304B2/en not_active Expired - Fee Related
-
2018
- 2018-01-11 US US15/868,395 patent/US10568989B2/en active Active
-
2019
- 2019-07-12 JP JP2019129823A patent/JP6897996B2/ja not_active Expired - Fee Related
- 2019-08-30 AU AU2019222935A patent/AU2019222935B2/en not_active Ceased
-
2020
- 2020-01-15 US US16/743,837 patent/US11771803B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1846793A (zh) * | 2005-04-14 | 2006-10-18 | 南方医院 | 一种组织工程骨及其构建与应用 |
| US20100247494A1 (en) * | 2009-03-23 | 2010-09-30 | The Texas A&M University System | Compositions of Mesenchymal Stem Cells to Regenerate Bone |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2542430C2 (ru) | Многомерный биоматериал и способ его приготовления | |
| Leucht et al. | Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals | |
| Jing et al. | Reengineering autologous bone grafts with the stem cell activator WNT3A | |
| US11771803B2 (en) | Enhancement of osteogenic potential of bone grafts | |
| CN109666629A (zh) | 人多能干细胞来源的外泌体、基于该外泌体的制剂及用途 | |
| JP7273418B2 (ja) | 脂肪由来幹細胞を含む無足場構造物用生体材料およびその作製方法 | |
| Mahon et al. | Extracellular matrix scaffolds derived from different musculoskeletal tissues drive distinct macrophage phenotypes and direct tissue-specific cellular differentiation | |
| JP5906183B2 (ja) | 骨障害を治療するための、および、体重を管理するための化合物および方法 | |
| ES2950632T3 (es) | Biomaterial que comprende células madre derivadas de tejido adiposo y método para producir el mismo | |
| CN111727238A (zh) | 胎儿组织提取物、生产提取物的方法及其用途 | |
| CN117545507A (zh) | 生化激活功能障碍骨骼干细胞以实现骨骼再生 | |
| Shi | Systemic Therapy of Inactivated-Bisphosphonate-Conjugated PEGylated NELL-1 (BP-NELL-PEG) for Spaceflight-Induced Osteoporosis | |
| WO2025259915A1 (en) | Use of matrix bound nanovesicles (mbv) for inhibition of osteoclasts | |
| Lewis | Characterising the therapeutic potential of PEPITEMin age-related bone loss, skeletal remodelling and repair | |
| Baral | Osseointegration of a Cementless Total Knee Arthroplasty in a Murine Model of Glucocorticoid Induced Osteoporosis | |
| KR20260060365A (ko) | 골 및 연골 퇴행의 치료를 위한 뇌 유래 골형성 인자 ccn3의 사용 방법 | |
| HK40029239B (en) | Non-human animal fetal tissue extract, methods for producing the extract, and the use thereof | |
| Wang | TLR4-mediated calvarial bone repair: investigating its role and potential use for regenerative medicine | |
| Ramnaraign | Endothelial Progenitor Cell Therapy for Fracture Healing in a Rat Femoral Defect Model: A Dose-Response Study | |
| Gasser | Osteoporosis: Limitations of current antiresorptive treatments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200324 |